We added the following clinical trials to Metastatic Trial Search for November 2024. To see all clinical trials, please visit Metastatic Trial Search.

ER or PR Positive Trials

• XB010 ADC for Advanced HR+ or Triple Negative Breast Cancer

HER2 Negative Trials

• Ifinatamab Deruxtecan ADC for Advanced HER2 Low or HER2 Negative Breast Cancer

Triple Negative Trials

• SMP-3124LP Targeted Therapy for Advanced Triple Negative Breast Cancer

• ProAgio Targeted Therapy with Chemotherapy for Advanced Triple Negative Breast Cancer

• BAL0891 Targeted Therapy Alone or With Chemotherapy for Advanced Triple Negative Breast Cancer

• BNT327 with Chemotherapy for Advanced Triple Negative Breast Cancer

Last Modified on October 31, 2024